ABSTRACT Particular types of hormonal contraceptives (HCs) and genital tract infections have been independently associated with risk of HIV-1 acquisition. We examined whether immunity in women using injectable depot medroxyprogesterone acetate (DMPA), combined oral contraceptives (COC), or no HCs differs by the presence of cervicovaginal infections. Immune mediators were quantified in cervical swabs from 832 HIV-uninfected reproductive-age Ugandans and Zimbabweans. Bacterial infections and HIV were diagnosed by PCR, genital herpes serostatus by enzyme-linked immunosorbent assay (ELISA), altered microflora by Nugent score, and Trichomonas vaginalis and Candida albicans infection by wet mount. Generalized linear models utilizing Box-Cox-Power...
Women account for nearly one-half of new human immunodeficiency virus type 1 (HIV-1) infections worl...
BACKGROUND: Evidence suggests that some forms of hormonal contraception (HC) increase women's risk o...
Globally, HIV/AIDS is a leading cause of morbidity worldwide among reproductive-aged cisgender women...
ABSTRACT Particular types of hormonal contraceptives (HCs) and genital tract infections have been in...
ObjectiveThe effects of sex hormones on the immune defenses of the female genital mucosa and its sus...
The observed association between Depo-Provera injectable use and increased HIV acquisition may be ca...
Abstract Background Hormonal contraceptives, particularly depot medroxyprogesterone acetate (DMPA), ...
Alterations to the mucosal environment of the female genital tract, such as genital inflammation, ha...
AbstractIntroduction:More than 100 million women worldwide use hormonal contraceptive, including usi...
<div><p>Soluble cervicovaginal biomarkers of inflammation, immune activation and risk of HIV acquisi...
Young women in sub-Saharan Africa are disproportionally affected by HIV infection and unintended pre...
Depot-medroxyprogesterone acetate is a commonly used injectable contraceptive that has been associat...
Background Effective contraception contributes substantially to reduced risk for maternal mortality....
Abstract While the prevalence of Human immunodeficiency virus-1 (HIV-1) infection has stabilized glo...
The role of sex hormones in regulating immune responses in the female genital tract has been recogni...
Women account for nearly one-half of new human immunodeficiency virus type 1 (HIV-1) infections worl...
BACKGROUND: Evidence suggests that some forms of hormonal contraception (HC) increase women's risk o...
Globally, HIV/AIDS is a leading cause of morbidity worldwide among reproductive-aged cisgender women...
ABSTRACT Particular types of hormonal contraceptives (HCs) and genital tract infections have been in...
ObjectiveThe effects of sex hormones on the immune defenses of the female genital mucosa and its sus...
The observed association between Depo-Provera injectable use and increased HIV acquisition may be ca...
Abstract Background Hormonal contraceptives, particularly depot medroxyprogesterone acetate (DMPA), ...
Alterations to the mucosal environment of the female genital tract, such as genital inflammation, ha...
AbstractIntroduction:More than 100 million women worldwide use hormonal contraceptive, including usi...
<div><p>Soluble cervicovaginal biomarkers of inflammation, immune activation and risk of HIV acquisi...
Young women in sub-Saharan Africa are disproportionally affected by HIV infection and unintended pre...
Depot-medroxyprogesterone acetate is a commonly used injectable contraceptive that has been associat...
Background Effective contraception contributes substantially to reduced risk for maternal mortality....
Abstract While the prevalence of Human immunodeficiency virus-1 (HIV-1) infection has stabilized glo...
The role of sex hormones in regulating immune responses in the female genital tract has been recogni...
Women account for nearly one-half of new human immunodeficiency virus type 1 (HIV-1) infections worl...
BACKGROUND: Evidence suggests that some forms of hormonal contraception (HC) increase women's risk o...
Globally, HIV/AIDS is a leading cause of morbidity worldwide among reproductive-aged cisgender women...